HoldingsChannel.com
| Date | Insider | Price | Amount |
|---|---|---|---|
| 12-28-2021 Insider Buy |
Hannah Valantine |
$12.96 CAGR » |
$44,475.94 3,433 shares |
| 3-15-2022 Insider Buy |
Andrea Ellis Director |
$8.39 CAGR » |
$100,680.00 12,000 shares |
| 3-14-2022 Insider Buy |
Douglas A. Dachille Director |
$8.19 CAGR » |
$81,934.00 10,000 shares |
| 1-5-2022 Insider Buy |
Douglas A. Dachille Director |
$16.36 CAGR » |
$163,650.00 10,000 shares |
| 12-29-2021 Insider Buy |
Brent L. Saunders Director |
$14.48 CAGR » |
$254,879.68 17,600 shares |
| 12-30-2021 Insider Buy |
Andrew Lo Director |
$13.18 CAGR » |
$98,850.00 7,500 shares |
| 12-29-2021 Insider Buy |
Hannah Valantine Director |
$14.23 CAGR » |
$25,101.72 1,764 shares |
| 12-29-2021 Insider Buy |
Fred Hassan Director |
$14.17 CAGR » |
$273,390.29 19,300 shares |
| 12-29-2021 Insider Buy |
James C. Momtazee Director |
$14.50 CAGR » |
$1,160,000.00 80,000 shares |
| 12-30-2021 Insider Buy |
Ronald J. Daniels Director |
$13.49 CAGR » |
$298,678.53 22,147 shares |
| 2-17-2021 Insider Buy |
Randal W. Scott Director |
$62.50 CAGR » |
$1,000,000.00 16,000 shares |
| 2-17-2021 Insider Buy |
Brian C. Stephenson See Remarks |
$62.50 CAGR » |
$500,000.00 8,000 shares |
| 7-1-2019 Insider Buy |
Uma Sinha Chief Scientific Officer |
$17.00 CAGR » |
$238,000.00 14,000 shares |
| 7-1-2019 Insider Buy |
Genetic Disorder L.P. KKR >10% Owner |
$17.00 CAGR » |
$45,000,700.00 2,647,100 shares |
| 7-1-2019 Insider Buy |
Brian C. Stephenson See Remark |
$17.00 CAGR » |
$943,500.00 55,500 shares |
| 7-1-2019 Insider Buy |
Michael Thomas Henderson See Remarks |
$17.00 CAGR » |
$119,000.00 7,000 shares |
| 6-27-2019 Insider Buy |
Global Investors LP Viking >10% Owner |
$17.00 CAGR » |
$80,000,300.00 4,705,900 shares |
| 6-27-2019 Insider Buy |
VIKING GLOBAL PERFORMANCE LLC >10% Owner |
$17.00 CAGR » |
$80,000,300.00 4,705,900 shares |
Also See: Institutional Holders of BBIO
Also See: SEC filings
|
Growth of $10,000.00 Without Dividends Reinvested |
||
| Start date: | 12/29/2021 | |
| End date: | 04/25/2024 | |
| Start price/share: | $14.19 | |
| End price/share: | $24.33 | |
| Dividends collected/share: | $0.00 | |
| Total return: | 71.46% | |
| Average Annual Total Return: | 26.16% | |
| Starting investment: | $10,000.00 | |
| Ending investment: | $17,147.22 | |
| Years: | 2.32 | |
BBIO Insider Buying
This Holdings Channel page has presented insider buying activity, covering Directors, officers (such as CEO, CFO, COO, etc.), and >10% owners (who are required to file form 4's with the SEC). Important institutional owners may not fall under these categories, but instead file their holdings quarterly on the latest form 13F filings. While recent BBIO insider buying activity is included, there may also be stock sales over this same period (Also See: SEC filings for sales and other details).
Also See: Funds Holding BBIO
 Free BBIO Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
|
|
|
Other companies seeing insider buying close in time to when the BBIO Insider Buying occurred are:
RRBI Insider Buying
|
